Illinois became the first state to require insurance companies to pay the costs of EpiPen injection medicines for children 18 and younger.

Two institutional-based health plans in New England have announced their plans to merge.

Pharmacy benefit managers (PBMs) are only keeping less than 1% of rebates in the Medicare Part D program, passing on the rest of drug savings to plan sponsors, a report from the Government Accountability Office (GAO) found.

Only 51% of consumers feel optimistic or safe when it comes to AI infiltrating the healthcare space in the form of helping providers in diagnostic decision making and care management, according to a recent survey from Blumberg Capital.

When Sarah Kliff, healthcare reporter for Vox, saw an emergency department bill charging more than $600 for an encounter that ended with a band-aid, she and the media company undertook a year-long project to explore as many ED bills as possible.

Enrollment of people who are ineligible for subsidies on the individual healthcare market appears to be slowing down, according to a recent report from CMS.

If IBM’s Watson goes down as an early failure of AI in healthcare, the fumble may be recorded as an unforced error made by humans who were determined to position the company as the first serious player on the field.  

Less than a year after coming aboard HHS as senior advisor to the agency’s secretary Alex Azar, for drug pricing reform, John O’Brien is stepping down from his position.